|
|
|
|
| LEADER |
01712 am a22002413u 4500 |
| 001 |
112734 |
| 042 |
|
|
|a dc
|
| 100 |
1 |
0 |
|a Heidenreich, Matthias
|e author
|
| 100 |
1 |
0 |
|a Massachusetts Institute of Technology. Department of Biological Engineering
|e contributor
|
| 100 |
1 |
0 |
|a Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
|e contributor
|
| 100 |
1 |
0 |
|a McGovern Institute for Brain Research at MIT
|e contributor
|
| 100 |
1 |
0 |
|a Heidenreich, Matthias
|e contributor
|
| 100 |
1 |
0 |
|a Zhang, Feng
|e contributor
|
| 700 |
1 |
0 |
|a Zhang, Feng
|e author
|
| 245 |
0 |
0 |
|a Applications of CRISPR-Cas systems in neuroscience
|
| 260 |
|
|
|b Nature Publishing Group,
|c 2017-12-13T16:18:11Z.
|
| 856 |
|
|
|z Get fulltext
|u http://hdl.handle.net/1721.1/112734
|
| 520 |
|
|
|a Genome-editing tools, and in particular those based on CRISPR-Cas (clustered regularly interspaced short palindromic repeat (CRISPR)-CRISPR-associated protein) systems, are accelerating the pace of biological research and enabling targeted genetic interrogation in almost any organism and cell type. These tools have opened the door to the development of new model systems for studying the complexity of the nervous system, including animal models and stem cell-derived in vitro models. Precise and efficient gene editing using CRISPR-Cas systems has the potential to advance both basic and translational neuroscience research.
|
| 520 |
|
|
|a National Institute of Mental Health (U.S.) (Grant 5DP1-MH100706)
|
| 520 |
|
|
|a National Institute of Mental Health (U.S.) (Grant 1R01-MH110049)
|
| 520 |
|
|
|a National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) (Grant 5R01DK097768-03)
|
| 655 |
7 |
|
|a Article
|
| 773 |
|
|
|t Nature Reviews Neuroscience
|
